ITGB5 and hepatocellular carcinoma: Through the inactivation of the WNT/β-catenin pathway in an ITGB5-dependent manner and the suppression of SIX2, miR-185 exerts anti-growth and anti-metastatic effects on HCC cells and reverses EMT.